Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
67%(2 trials)

Phase Distribution

Ph early_phase_1
1
17%
Ph not_applicable
3
50%
Ph phase_1
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
N/A3 (60.0%)

Trials by Status

active_not_recruiting117%
recruiting117%
completed350%
not_yet_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6